Cepheid revenue was $538.58 m in FY, 2015 which is a 14.6% year over year increase from the previous period.

## Founding Date | 1996 |

## Total Funding | $27.1 m |

## Investors | Wheatley Partners, Innogenetics |

Cepheid is a subsidiary of Danaher

USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|---|

## Revenue | 212.5m | 277.6m | 331.2m | 401.3m | 470.1m | 538.6m |

| 17% | 15% | ||||

## Cost of goods sold | 105.1m | 122.8m | 153.4m | 207.9m | 229.3m | 269.9m |

## Gross profit | 107.3m | 154.7m | 177.8m | 193.4m | 240.8m | 268.7m |

| 51% | 56% | 54% | 48% | 51% | 50% |

## Sales and marketing expense | 38.8m | 50.7m | 61.9m | 79.9m | 97.8m | 115.4m |

## R&D expense | 42.5m | 59.4m | 71.7m | 80.2m | 96.9m | 115.8m |

## General and administrative expense | 24.5m | 36.0m | 43.3m | 41.7m | 55.0m | 62.6m |

## Operating expense total | 112.7m | 150.9m | 199.2m | 209.4m | 274.9m | 299.6m |

## EBIT | (5.3m) | 3.8m | (21.3m) | (16.0m) | (34.1m) | (30.9m) |

| (3%) | 1% | (6%) | (4%) | (7%) | (6%) |

## Interest expense | 340.0k | 511.0k | 147.0k | 807.0k | 13.5m | 16.4m |

## Interest income | 168.0k | 23.0k | 26.0k | 45.0k | 1.1m | 1.9m |

## Pre tax profit | (6.3m) | 2.7m | (21.3m) | (16.8m) | (47.6m) | (47.3m) |

## Income tax expense | (419.0k) | 45.0k | (1.3m) | 1.1m | 2.6m | 1.3m |

## Net Income | (5.9m) | 2.6m | (20.0m) | (18.0m) | (50.1m) | (48.5m) |

USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|---|

## Cash | 79.5m | 115.0m | 95.8m | 66.1m | 96.7m | 112.6m |

## Accounts Receivable | 28.0m | 35.4m | 44.0m | 52.2m | 68.8m | 66.6m |

## Prepaid Expenses | 4.1m | 5.2m | 9.4m | 13.0m | 24.3m | 18.5m |

## Inventories | 37.6m | 62.2m | 70.1m | 103.9m | 132.6m | 148.7m |

## Current Assets | 149.3m | 217.9m | 219.3m | 244.0m | 519.1m | 556.5m |

## PP&E | 27.4m | 35.8m | 54.8m | 84.9m | 115.8m | 127.6m |

## Goodwill | 18.6m | 18.4m | 37.7m | 39.7m | 39.7m | 39.7m |

## Total Assets | 220.6m | 286.7m | 331.5m | 394.6m | 793.6m | 821.6m |

## Accounts Payable | 22.0m | 32.2m | 33.7m | 52.6m | 50.4m | 57.8m |

## Short-term debt | 1.7m | 24.7m | 183.0k | 194.0k | ||

## Current Liabilities | 53.7m | 69.7m | 72.3m | 95.5m | 137.8m | 142.5m |

## Long-term debt | 5.0m | 1.7m | 1.5m | |||

## Total Debt | 6.7m | 24.7m | 1.9m | |||

## Total Liabilities | 66.9m | 74.8m | 84.0m | 109.4m | 439.4m | 451.7m |

## Common Stock | 288.4m | 324.2m | 355.9m | 383.4m | 422.2m | 449.7m |

## Preferred Stock | ||||||

## Additional Paid-in Capital | 72.7m | 93.1m | 117.2m | 145.9m | 225.5m | 263.4m |

## Retained Earnings | (208.2m) | (205.6m) | (225.6m) | (243.6m) | (293.7m) | (342.2m) |

## Total Equity | 153.7m | 211.8m | 247.5m | 285.2m | 354.2m | 370.0m |

## Financial Leverage | 1.4 x | 1.4 x | 1.3 x | 1.4 x | 2.2 x | 2.2 x |

USD | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|---|---|---|

## Net Income | (5.9m) | 2.6m | (20.0m) | (18.0m) | (50.1m) | (48.5m) |

## Depreciation and Amortization | 9.3m | 10.3m | 13.4m | 23.2m | 26.3m | 6.3m |

## Accounts Receivable | (4.4m) | (7.8m) | (6.4m) | (7.0m) | (16.6m) | 2.3m |

## Inventories | 124.0k | (24.0m) | (5.1m) | (32.6m) | (29.3m) | (15.1m) |

## Accounts Payable | (5.1m) | 11.3m | (5.7m) | 17.3m | 3.4m | 4.2m |

## Cash From Operating Activities | 27.3m | 27.0m | 2.9m | 15.0m | 9.2m | 31.1m |

## Purchases of PP&E | (13.0m) | (18.9m) | (23.1m) | (47.5m) | (47.0m) | (37.7m) |

## Cash From Investing Activities | 9.7m | (20.9m) | (49.3m) | (71.0m) | (325.7m) | (39.9m) |

## Short-term Borrowings | (618.0k) | (6.7m) | (72.0k) | (874.0k) | (180.0k) | (162.0k) |

## Cash From Financing Activities | 6.5m | 29.2m | 27.2m | 26.6m | 349.2m | 27.5m |

## Net Change in Cash | 43.8m | 35.5m | (19.2m) | (29.7m) | 30.6m | 15.9m |

## Interest Paid | 225.0k | 207.0k | 124.0k | 109.0k | ||

## Income Taxes Paid | 1.1m | 632.0k |